The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Phenotypic Drug Discovery-Global Market Insights and Sales Trends 2025
Synopsis
The global Phenotypic Drug Discovery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Phenotypic Drug Discovery in various end use industries. The expanding demands from the Cancer, Viral Infection, Genetic Disease and Others, are propelling Phenotypic Drug Discovery market. Platform, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Phenotypic Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Phenotypic Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Phenotypic Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Phenotypic Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Phenotypic Drug Discovery covered in this report include Eurofins Discovery, Sygnature Discovery, PsychoGenics, siTOOLs Biotech, PhoreMost, Charles River, MaxWell and Arctoris, etc.
The global Phenotypic Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris
Global Phenotypic Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Phenotypic Drug Discovery market, Segment by Type:
Platform
Service
Global Phenotypic Drug Discovery market, by Application
Cancer
Viral Infection
Genetic Disease
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Phenotypic Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Phenotypic Drug Discovery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Phenotypic Drug Discovery in various end use industries. The expanding demands from the Cancer, Viral Infection, Genetic Disease and Others, are propelling Phenotypic Drug Discovery market. Platform, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Phenotypic Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Phenotypic Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Phenotypic Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Phenotypic Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Phenotypic Drug Discovery covered in this report include Eurofins Discovery, Sygnature Discovery, PsychoGenics, siTOOLs Biotech, PhoreMost, Charles River, MaxWell and Arctoris, etc.
The global Phenotypic Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris
Global Phenotypic Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Phenotypic Drug Discovery market, Segment by Type:
Platform
Service
Global Phenotypic Drug Discovery market, by Application
Cancer
Viral Infection
Genetic Disease
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Phenotypic Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Phenotypic Drug Discovery
1.1 Phenotypic Drug Discovery Market Overview
1.1.1 Phenotypic Drug Discovery Product Scope
1.1.2 Phenotypic Drug Discovery Market Status and Outlook
1.2 Global Phenotypic Drug Discovery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Phenotypic Drug Discovery Market Size by Region (2018-2029)
1.4 Global Phenotypic Drug Discovery Historic Market Size by Region (2018-2023)
1.5 Global Phenotypic Drug Discovery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Phenotypic Drug Discovery Market Size (2018-2029)
1.6.1 North America Phenotypic Drug Discovery Market Size (2018-2029)
1.6.2 Europe Phenotypic Drug Discovery Market Size (2018-2029)
1.6.3 Asia-Pacific Phenotypic Drug Discovery Market Size (2018-2029)
1.6.4 Latin America Phenotypic Drug Discovery Market Size (2018-2029)
1.6.5 Middle East & Africa Phenotypic Drug Discovery Market Size (2018-2029)
2 Phenotypic Drug Discovery Market by Type
2.1 Introduction
2.1.1 Platform
2.1.2 Service
2.2 Global Phenotypic Drug Discovery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2018-2023)
2.2.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Phenotypic Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Phenotypic Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Phenotypic Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Phenotypic Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Phenotypic Drug Discovery Revenue Breakdown by Type (2018-2029)
3 Phenotypic Drug Discovery Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Viral Infection
3.1.3 Genetic Disease
3.1.4 Others
3.2 Global Phenotypic Drug Discovery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2018-2023)
3.2.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Phenotypic Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Phenotypic Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Phenotypic Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Phenotypic Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Phenotypic Drug Discovery Revenue Breakdown by Application (2018-2029)
4 Phenotypic Drug Discovery Competition Analysis by Players
4.1 Global Phenotypic Drug Discovery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2022)
4.3 Date of Key Players Enter into Phenotypic Drug Discovery Market
4.4 Global Top Players Phenotypic Drug Discovery Headquarters and Area Served
4.5 Key Players Phenotypic Drug Discovery Product Solution and Service
4.6 Competitive Status
4.6.1 Phenotypic Drug Discovery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eurofins Discovery
5.1.1 Eurofins Discovery Profile
5.1.2 Eurofins Discovery Main Business
5.1.3 Eurofins Discovery Phenotypic Drug Discovery Products, Services and Solutions
5.1.4 Eurofins Discovery Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.1.5 Eurofins Discovery Recent Developments
5.2 Sygnature Discovery
5.2.1 Sygnature Discovery Profile
5.2.2 Sygnature Discovery Main Business
5.2.3 Sygnature Discovery Phenotypic Drug Discovery Products, Services and Solutions
5.2.4 Sygnature Discovery Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.2.5 Sygnature Discovery Recent Developments
5.3 PsychoGenics
5.3.1 PsychoGenics Profile
5.3.2 PsychoGenics Main Business
5.3.3 PsychoGenics Phenotypic Drug Discovery Products, Services and Solutions
5.3.4 PsychoGenics Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.3.5 siTOOLs Biotech Recent Developments
5.4 siTOOLs Biotech
5.4.1 siTOOLs Biotech Profile
5.4.2 siTOOLs Biotech Main Business
5.4.3 siTOOLs Biotech Phenotypic Drug Discovery Products, Services and Solutions
5.4.4 siTOOLs Biotech Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.4.5 siTOOLs Biotech Recent Developments
5.5 PhoreMost
5.5.1 PhoreMost Profile
5.5.2 PhoreMost Main Business
5.5.3 PhoreMost Phenotypic Drug Discovery Products, Services and Solutions
5.5.4 PhoreMost Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.5.5 PhoreMost Recent Developments
5.6 Charles River
5.6.1 Charles River Profile
5.6.2 Charles River Main Business
5.6.3 Charles River Phenotypic Drug Discovery Products, Services and Solutions
5.6.4 Charles River Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.6.5 Charles River Recent Developments
5.7 MaxWell
5.7.1 MaxWell Profile
5.7.2 MaxWell Main Business
5.7.3 MaxWell Phenotypic Drug Discovery Products, Services and Solutions
5.7.4 MaxWell Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.7.5 MaxWell Recent Developments
5.8 Arctoris
5.8.1 Arctoris Profile
5.8.2 Arctoris Main Business
5.8.3 Arctoris Phenotypic Drug Discovery Products, Services and Solutions
5.8.4 Arctoris Phenotypic Drug Discovery Revenue (US$ Million) & (2018-2023)
5.8.5 Arctoris Recent Developments
6 North America
6.1 North America Phenotypic Drug Discovery Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Phenotypic Drug Discovery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Phenotypic Drug Discovery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Phenotypic Drug Discovery Market Dynamics
11.1 Phenotypic Drug Discovery Industry Trends
11.2 Phenotypic Drug Discovery Market Drivers
11.3 Phenotypic Drug Discovery Market Challenges
11.4 Phenotypic Drug Discovery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
